Waters Corporation Long-term assets (Other)

Long-term assets (Other) of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long-term assets (Other) growth rates and interactive chart. All other non-current assets that do not fit the categories above.

Highlights and Quick Summary

  • Long-term assets (Other) for the quarter ending December 30, 2020 was $149 Million (a 2.58% increase compared to previous quarter)
  • Year-over-year quarterly Long-term assets (Other) increased by 5.05%
  • Annual Long-term assets (Other) for 2020 was $149 Million (a 8.06% increase from previous year)
  • Annual Long-term assets (Other) for 2019 was $138 Million (a 15.9% increase from previous year)
  • Annual Long-term assets (Other) for 2018 was $119 Million (a 1.66% increase from previous year)
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long-term assets (Other) of Waters Corporation

Most recent Long-term assets (Other)of WAT including historical data for past 10 years.

Interactive Chart of Long-term assets (Other) of Waters Corporation

Waters Corporation Long-term assets (Other) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $148.63 $144.89 $154.6 $141.48 $148.63
2019 $137.53 $159.2 $142.6 $121.25 $137.53
2018 $118.66 $123.11 $122.35 $107.5 $118.66
2017 $116.73 $158.2 $134.44 $133.05 $116.73
2016 $130.36 $134.63 $141.52 $140.73 $130.36
2015 $146.9 $126.89 $120.49 $116.81 $146.9
2014 $151.4 $129.22 $127.18 $120.42 $151.4
2013 $111.98 $111.4 $110.84 $106.78 $111.98
2012 $100.17 $69.39 $61.12 $62.54 $100.17
2011 $54.97 $60.6 $64.12 $61.89 $54.97
2010 $53.0 $76.94 $51.76 $53.0

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.